Skip to main content

SciSparc Ltd.

corporate_fare Company Profile

SciSparc Ltd.

SPRC·NASDAQ·Life Sciences·CIK 0001611746

SciSparc Ltd. is a clinical-stage pharmaceutical company that develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110, which is being developed for the treatment of Tourette syndrome and Alzheimer's disease and agitation. Another program, SCI-210, targets autism spectrum disorder and status epilepticus. The company also develops CannAmide, an anti-inflammatory and chronic pain solution. In addition to its drug development, SciSparc Ltd. sells hemp seed oil-based products and other related items. The company has an agreement with Procaps for the development and commercial manufacturing of SCI-110, palmitoylethanolamide oral tablets, and CannAmide in softgel capsule form. SciSparc Ltd. also has an agreement with The Israeli Medical Center for Alzheimer's to conduct a phase IIa clinical trial. This trial evaluates the safety, tolerability, and efficacy of SCI-110 in patients with Alzheimer's disease and agitation. Furthermore, the company has a collaboration with Clearmind Medicine Inc. SciSparc Ltd. was incorporated in 2004 and is headquartered in Tel Aviv-Yafo, Israel. The company was formerly known as Therapix Biosciences Ltd. and changed its name to SciSparc Ltd. in January 2021.

SciSparc Ltd. (NASDAQ:SPRC) is a publicly traded company in the Life Sciences sector. Wiseek monitors SPRC SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • NeuroThera Labs, SciSparc Subsidiary, Closes CliniQuantum Acquisition Valued at $9.46M
  • SciSparc Subsidiary NeuroThera Labs Receives Conditional TSX Approval for CliniQuantum Acquisition, Amends Terms
  • SciSparc Subsidiary Nears Major Acquisition Close with Conditional Regulatory Approval
  • SciSparc Achieves Conditional Nasdaq Compliance, Averting Immediate Delisting
  • SciSparc Reports Significant Losses, Going Concern Doubt, and Major Loan Impairment Exceeding Market Cap

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$856K
Net Income
-$12.56M
Diluted EPS
$98.07
Op. Cash Flow
-$4.14M
Gross Profit
$631K
Operating Income
-$8.37M
Cash & Equivalents
$4.59M
Total Debt
$356K
Debt / Equity
0.07×
Net Margin
-14.68×
Shares Outstanding
365.44K sh
Source: 20-F · filed 2026-04-29 · accession 0001213900-26-049322

Insider Transactions

SPRC files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

Browse all tickers starting with S →
$8.55
52-week range · as of 2026-05-29 $2.98 – $80.1
Market cap
$4.9M
Volume
24.3K (0.0× avg)
3-mo avg 1.6M
Live data · 2026-06-14 03:51 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed SPRC - Latest Insights

SPRC
Jun 03, 2026, 5:15 PM EDT
Source: TheNewswire
Importance Score:
7
Price at Filing: $9.45
Real-time Price: $8.55 info
Change: -$0.900 (-10%) info
Market Cap: $4.901M info
SPRC
May 29, 2026, 7:40 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $9.24
Real-time Price: $8.55 info
Change: -$0.690 (-7%) info
Market Cap: $4.901M info
SPRC
May 28, 2026, 8:40 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $4.54
Real-time Price: $8.55 info
Change: +$4.01 (+88%) info
Market Cap: $4.901M info
SPRC
May 11, 2026, 8:00 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $6.20
Real-time Price: $8.55 info
Change: +$2.35 (+38%) info
Market Cap: $4.901M info
SPRC
Apr 29, 2026, 4:20 PM EDT
Filing Type: 20-F
Importance Score:
9
Price at Filing: $9.04
Real-time Price: $8.55 info
Change: -$0.4912 (-5%) info
Market Cap: $4.901M info
SPRC
Mar 16, 2026, 8:21 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $4.33
Real-time Price: $8.55 info
Change: +$4.22 (+97%) info
Market Cap: $4.901M info
SPRC
Mar 12, 2026, 4:41 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $4.22
Real-time Price: $8.55 info
Change: +$4.33 (+103%) info
Market Cap: $4.901M info
SPRC
Mar 12, 2026, 7:55 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $4.56
Real-time Price: $8.55 info
Change: +$3.99 (+88%) info
Market Cap: $4.901M info
SPRC
Mar 10, 2026, 9:28 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $4.78
Real-time Price: $8.55 info
Change: +$3.77 (+79%) info
Market Cap: $4.901M info
SPRC
Mar 02, 2026, 8:08 AM EST
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.493
Real-time Price: $8.55 info
Change: +$8.06 (+1,634%) info
Market Cap: $4.901M info
SPRC
Feb 17, 2026, 5:27 PM EST
Filing Type: F-3
Importance Score:
9
Price at Filing: $0.576
Real-time Price: $8.55 info
Change: +$7.97 (+1,384%) info
Market Cap: $4.901M info
SPRC
Feb 17, 2026, 4:01 PM EST
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.576
Real-time Price: $8.55 info
Change: +$7.97 (+1,384%) info
Market Cap: $4.901M info
SPRC
Feb 12, 2026, 4:02 PM EST
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.5973
Real-time Price: $8.55 info
Change: +$7.95 (+1,331%) info
Market Cap: $4.901M info
SPRC
Feb 03, 2026, 4:36 PM EST
Filing Type: F-3
Importance Score:
9
Price at Filing: $0.7545
Real-time Price: $8.55 info
Change: +$7.80 (+1,033%) info
Market Cap: $4.901M info
SPRC
Feb 02, 2026, 4:01 PM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.753
Real-time Price: $8.55 info
Change: +$7.80 (+1,035%) info
Market Cap: $4.901M info
SPRC
Jan 26, 2026, 4:01 PM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.930
Real-time Price: $8.55 info
Change: +$7.62 (+819%) info
Market Cap: $4.901M info
SPRC
Jan 14, 2026, 8:29 AM EST
Filing Type: 424B5
Importance Score:
9
Price at Filing: $1.12
Real-time Price: $8.55 info
Change: +$7.43 (+663%) info
Market Cap: $4.901M info
SPRC
Jan 13, 2026, 9:01 AM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $1.20
Real-time Price: $8.55 info
Change: +$7.35 (+613%) info
Market Cap: $4.901M info
SPRC
Jan 13, 2026, 7:10 AM EST
Filing Type: 6-K
Importance Score:
9
Price at Filing: $1.20
Real-time Price: $8.55 info
Change: +$7.35 (+613%) info
Market Cap: $4.901M info
SPRC
Jan 12, 2026, 4:09 PM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $1.45
Real-time Price: $8.55 info
Change: +$7.10 (+490%) info
Market Cap: $4.901M info